Author

Piyush B. Madhamshettiwar

Peter MacCallum Cancer Centre

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Adrià ClosaiD· 1 shared Amee J. GeorgeiD· 1 shared Cathryn M. Gould· 1 shared Dani Tutuka· 1 shared Jasmina FrawleyiD· 1 shared Jason A. PowelliD· 1 shared Jirawas SornkomiD· 1 shared Katherine M. HannaniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adrià ClosaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Novel RNA Polymerase I and Cyclin Dependent Kinase combination therapy for the treatment of aggressive Acute Myeloid Leukemia.

Nadine Hein, Perlita Poh, Jason A. Powell, Lorena Núñez-Villacís, Sarah Sant’Anna Maranhão, Maurits Evers, Jirawas Sornkom, Victoria S. Pope, Priscilla Soo, Adrià Closa, Jasmina Frawley, Sheren J. Al-Obaidi, Cathryn M. Gould, Piyush B. Madhamshettiwar, Kaylene J. Simpson, , Rita Ferreira

This paper identifies a synergistic combination of RNA Polymerase I inhibitor CX-5461 and CDK inhibitor Dinaciclib that enhances therapeutic efficacy in AML by inducing nucleolar stress and cell cycle arrest.

Leukemia · Oct 8, 2026Peer-reviewedCancer Biology